STRASS 2 - ETUDE 1809-STBSG

A randomized phase III study of neoadjuvant chemotherapy;followed by surgery versus surgery alone for patients with;High Risk RetroPeritoneal Sarcoma (STRASS 2)

Open at Paris since : 09/11/2020
Target : Adult
Phase : Phase III

Trial description

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival.;After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.

Url of the trial

Main investigator

SYLVIE BONVALOT

Professeur - Médecin

Contact